Skip to main content

Global recognition to iLoF, an EIT Health-supported start-up

iLoF listed as one of the top 150 digital health start-ups worldwide by CB Insights

Just as EIT Health prepares to announce the two challenge areas selected for this year’s Wild Card programme, one of the last year’s recipients has been included in a prestigious list recognised throughout the health industry.

iLoF (Intelligent Lab on Fiber), a start-up formed by the 2019 Wild Card programme, have been listed in CB Insights’ Digital Health 150, an annual ranking of the most promising digital health start-ups in the world.

The EIT Health Wild Card Programme generates and supports high-risk, innovative projects with transformative potential. The annual call is open to innovators who want to change the course of their future and ours. The Wild Card programme groups the innovators into teams for a competition, and the winning teams form a start-up and receive EIT Health support for their new venture. The EIT Health Wild Card programme provides the new start-ups with world-class training and mentoring, and up to €1.6 million in investment.

iLoF received Wild Card support so that they could develop a solution using artificial intelligence (AI) and photonics to screen for Alzheimer’s disease, as current screening techniques are invasive and painful. Using its non-invasive, portable and inexpensive test, iLoF seeks to transform the patients’ experience and make clinical trials convenient and patient-centric. iLoF says it hopes to save 40% of the total costs and 70% of the time spent on screening and stratifying Alzheimer’s patients for clinical trials, thereby becoming an enabler in finding treatments for the disease.

Since their launch through the Wild Card programme, iLoF has been gaining investment and recognition with their latest honours being inclusion in CB Insights’ Digital Health 150. The 150 companies on this list were selected based on factors including patent activity, business relations, investor profile, news sentiment analysis, proprietary Mosaic scores, market potential, competitive landscape, team strength and tech novelty.

iLoF have already enjoyed significant success, with the founders named in Forbes 30 under 30 and an investment of $1 million from M12 and Mayfield.

If you think your start-up has what it takes to become a Wild Card venture; the next call will open at the end of September. Keep an eye on the EIT Health's website for more information.